Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Corrigendum to "TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer" [Canc. Lett. 412 (2018) 155-169].

Bogusławska J, Rodzik K, Popławski P, Kędzierska H, Rybicka B, Sokół E, Tański Z, Piekiełko-Witkowska A.

Cancer Lett. 2020 Jan 28. pii: S0304-3835(20)30014-8. doi: 10.1016/j.canlet.2020.01.006. [Epub ahead of print] No abstract available.


MicroRNA-Mediated Metabolic Reprograming in Renal Cancer.

Bogusławska J, Popławski P, Alseekh S, Koblowska M, Iwanicka-Nowicka R, Rybicka B, Kędzierska H, Głuchowska K, Hanusek K, Tański Z, Fernie AR, Piekiełko-Witkowska A.

Cancers (Basel). 2019 Nov 20;11(12). pii: E1825. doi: 10.3390/cancers11121825.


Single-Layer Sutures in Abdominal Cavity Surgery.

Tański Z, Jarząbek Z, Konowalski B, Truszkowski M, Biedrzycki J, Kuzaka B, Kuzaka P.

Pol Przegl Chir. 2019 Aug 31;91(5):12-20. doi: 10.5604/01.3001.0013.4538.


microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3'UTRs.

Sokół E, Kędzierska H, Czubaty A, Rybicka B, Rodzik K, Tański Z, Bogusławska J, Piekiełko-Witkowska A.

Exp Cell Res. 2018 Feb 15;363(2):208-217. doi: 10.1016/j.yexcr.2018.01.009. Epub 2018 Jan 10.


TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer.

Bogusławska J, Rodzik K, Popławski P, Kędzierska H, Rybicka B, Sokół E, Tański Z, Piekiełko-Witkowska A.

Cancer Lett. 2018 Jan 1;412:155-169. doi: 10.1016/j.canlet.2017.10.019. Epub 2017 Oct 25. Erratum in: Cancer Lett. 2020 Jan 28;:.


Integrated transcriptomic and metabolomic analysis shows that disturbances in metabolism of tumor cells contribute to poor survival of RCC patients.

Popławski P, Tohge T, Bogusławska J, Rybicka B, Tański Z, Treviño V, Fernie AR, Piekiełko-Witkowska A.

Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):744-752. doi: 10.1016/j.bbadis.2016.12.011. Epub 2016 Dec 22.


Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer.

Kędzierska H, Popławski P, Hoser G, Rybicka B, Rodzik K, Sokół E, Bogusławska J, Tański Z, Fogtman A, Koblowska M, Piekiełko-Witkowska A.

Int J Mol Sci. 2016 Sep 28;17(10). pii: E1598.


Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer.

Boguslawska J, Kedzierska H, Poplawski P, Rybicka B, Tanski Z, Piekielko-Witkowska A.

J Urol. 2016 Jun;195(6):1892-902. doi: 10.1016/j.juro.2015.11.050. Epub 2015 Nov 26.


Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.

Piekielko-Witkowska A, Wiszomirska H, Wojcicka A, Poplawski P, Boguslawska J, Tanski Z, Nauman A.

PLoS One. 2010 Oct 27;5(10):e13690. doi: 10.1371/journal.pone.0013690.


Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma.

Master A, Wójcicka A, Piekiełko-Witkowska A, Bogusławska J, Popławski P, Tański Z, Darras VM, Williams GR, Nauman A.

Biochim Biophys Acta. 2010 Nov;1802(11):995-1005. doi: 10.1016/j.bbadis.2010.07.025. Epub 2010 Aug 3.


Disturbed expression of type 1 iodothyronine deiodinase splice variants in human renal cancer.

Piekielko-Witkowska A, Master A, Wojcicka A, Boguslawska J, Brozda I, Tanski Z, Nauman A.

Thyroid. 2009 Oct;19(10):1105-13. doi: 10.1089/thy.2008.0284.


Overexpression of E2F1 in clear cell renal cell carcinoma: a potential impact of erroneous regulation by thyroid hormone nuclear receptors.

Turowska O, Nauman A, Pietrzak M, Popławski P, Master A, Nygard M, Bondesson M, Tanski Z, Puzianowska-Kuznicka M.

Thyroid. 2007 Nov;17(11):1039-48.


Elevated cyclin E level in human clear cell renal cell carcinoma: possible causes and consequences.

Nauman A, Turowska O, Poplawski P, Master A, Tanski Z, Puzianowska-Kuznicka M.

Acta Biochim Pol. 2007;54(3):595-602. Epub 2007 Aug 28.


Vitamin D receptor binding to DNA is altered without the change in its expression in human renal clear cell cancer.

Madej A, Puzianowska-Kuznicka M, Tanski Z, Nauman J, Nauman A.

Nephron Exp Nephrol. 2003;93(4):e150-7.


Supplemental Content

Loading ...
Support Center